Evaluation of the Efficacy of VR on Pain and Anxiety When Performing an Ultrasound-controlled Ankle Block.

NCT ID: NCT03677323

Last Updated: 2019-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-02

Study Completion Date

2019-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to observe or not a reduction on pain and anxiety felt by the patient when performing an ultrasound-controlled ankle block in preparation for forefoot surgery, using a virtual reality device instead of drug sedation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, in preparation for forefoot surgery, the realization of the ankle block is accompanied by drug sedation.

The investigator's randomized study aims to compare the anxiety and pain experienced by patients who have benefited from drug sedation with those of patients who benefited from the virtual reality device at the time of the realization of the ankle block.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hallux Valgus Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual reality

The virtual reality device will consist of the virtual reality headset and headphones for full immersion.

Group Type EXPERIMENTAL

Virtual reality

Intervention Type DEVICE

The patient will have the choice between different environments and the use of this device will remain under the control of the medical team.

The patient will wear the virtual reality device at the time of the completion of the ankle block and will remove it once the nerve puncture is complete.

Drug sedation

The sedation group will benefit from drug sedation used in current practice, that is to say an association of Sufentanil, Droleptan and Propofol.

Group Type ACTIVE_COMPARATOR

Droleptan

Intervention Type DRUG

Venous administration of 1.25 mg of Droleptan

Propofol

Intervention Type DRUG

Venous administration of 20 mg of Propofol

Sufentanyl

Intervention Type DRUG

Venous administration of 5 μg of Sufentanyl.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality

The patient will have the choice between different environments and the use of this device will remain under the control of the medical team.

The patient will wear the virtual reality device at the time of the completion of the ankle block and will remove it once the nerve puncture is complete.

Intervention Type DEVICE

Droleptan

Venous administration of 1.25 mg of Droleptan

Intervention Type DRUG

Propofol

Venous administration of 20 mg of Propofol

Intervention Type DRUG

Sufentanyl

Venous administration of 5 μg of Sufentanyl.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VR Sedation Sedation Sedation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with medical insurance
* Major patient requiring a Hallux Valgus surgery
* Patient who received information about study and signes a consent to participate in the study

Exclusion Criteria

* Minor patient
* Patient participating in another interventional study
* Patient refusing to sign the consent form
* Patient for whom it is impossible to give informed information
* Patient who had previously undergone forefoot surgery under locoregional anesthesia
* Patient with poor skin condition or infection at puncture sites
* Patient refusing locoregional anesthesia
* Patient under the protection of justice, under curatorship or under tutorship
* Patient undergoing anxiolytic or antidepressant treatment
* Photosensitive epileptic patient
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinique Saint Jean, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas PILLANT, MD

Role: PRINCIPAL_INVESTIGATOR

Clinique Saint Jean, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Saint Jean

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Mosso JL, Gorini A, De La Cerda G, Obrador T, Almazan A, Mosso D, Nieto JJ, Riva G. Virtual reality on mobile phones to reduce anxiety in outpatient surgery. Stud Health Technol Inform. 2009;142:195-200.

Reference Type BACKGROUND
PMID: 19377147 (View on PubMed)

Furman E, Jasinevicius TR, Bissada NF, Victoroff KZ, Skillicorn R, Buchner M. Virtual reality distraction for pain control during periodontal scaling and root planing procedures. J Am Dent Assoc. 2009 Dec;140(12):1508-16. doi: 10.14219/jada.archive.2009.0102.

Reference Type BACKGROUND
PMID: 19955069 (View on PubMed)

Patterson DR, Jensen MP, Wiechman SA, Sharar SR. Virtual reality hypnosis for pain associated with recovery from physical trauma. Int J Clin Exp Hypn. 2010 Jul;58(3):288-300. doi: 10.1080/00207141003760595.

Reference Type BACKGROUND
PMID: 20509069 (View on PubMed)

Nilsson S, Finnstrom B, Kokinsky E, Enskar K. The use of Virtual Reality for needle-related procedural pain and distress in children and adolescents in a paediatric oncology unit. Eur J Oncol Nurs. 2009 Apr;13(2):102-9. doi: 10.1016/j.ejon.2009.01.003. Epub 2009 Feb 20.

Reference Type BACKGROUND
PMID: 19230769 (View on PubMed)

Konstantatos AH, Angliss M, Costello V, Cleland H, Stafrace S. Predicting the effectiveness of virtual reality relaxation on pain and anxiety when added to PCA morphine in patients having burns dressings changes. Burns. 2009 Jun;35(4):491-9. doi: 10.1016/j.burns.2008.08.017. Epub 2008 Dec 27.

Reference Type BACKGROUND
PMID: 19111995 (View on PubMed)

Wright JL, Hoffman HG, Sweet RM. Virtual reality as an adjunctive pain control during transurethral microwave thermotherapy. Urology. 2005 Dec;66(6):1320. doi: 10.1016/j.urology.2005.06.123.

Reference Type BACKGROUND
PMID: 16360473 (View on PubMed)

Burt DE. Virtual reality in anaesthesia. Br J Anaesth. 1995 Oct;75(4):472-80. doi: 10.1093/bja/75.4.472. No abstract available.

Reference Type BACKGROUND
PMID: 7488491 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LOCAL2017-TP02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.